NCT06979596
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06979596
Title A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Acronym OMAHA-015
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | ESP | BRA | ARG


No variant requirements are available.